It’s a concept that both scares and delights: the possibility that aging might not be an inevitable human fate, as was once assumed. It seemed like the kind of thing that only exists in science fiction along with flying cars and teleportation for the foreseeable future.
Now though, we have a new and rapidly growing tool for doing just that: artificial intelligence.
Researchers and other experts are currently suggesting that artificial intelligence is capable of solving one of the hardest questions in biology, how to decelerate, halt and reverse the process of ageing itself. This is not necessarily about making us live longer.
It may be possible to use AI to achieve the biological equivalent of living healthier for longer, as seen with this report.
But I’ll put a pause to that for a second. You may ask: “But how can AI be used to achieve this?” Well, as this explains in more detail, researchers can use AI to model how cells work, how proteins fold and which compounds can work together, instead of using real-life tests to test these interactions and reactions.
In doing so, scientists can use AI to replicate multiple experiments to work out the potential results, and these are all occurring much faster than traditional scientific studies.
This is also the reason why biotech companies are making significant developments in 2025.
That said, a dose of reality is in order. Many researchers don’t share the enthusiasm for imminent life-extending interventions.
They see aging not as a single problem with a single fix, but rather as a complex network of interlocking processes, the mechanisms of which we still do not fully understand. AI can help, no doubt, but it’s certainly no silver bullet.
In the face of these caveats, however, one thing is certain, lots of investors are betting on the power of artificial intelligence to extend human lifespan.
Billionaires and venture capitalists, as well as big pharma firms, all see the same thing: AI can fast-track scientific discovery, which might translate into longer lives.
Some companies are already applying AI to the identification of so-called “aging biomarkers,” which are molecular signals in the body that reveal how quickly a person is aging from the inside out; that development in and of itself is a major milestone, as emerging biotech companies are focusing on.
There’s also an awkward side issue that lingers: who gets to have this? If AI does result in longer lifespans, it certainly won’t come equally to everyone all at once.
Will it be another example of the rich getting richer (and living longer)? This issue, and the related concerns of equity and fairness, are already being discussed as AI transforms healthcare systems in different parts of the world.
Then there’s the human part. In other words, everyone wants the same thing, more time, more birthdays, more conversations, more second chances. But if there was more time, how would we spend it?
We might solve the aging problem, but we’d be faced with dozens of other issues. It’s true that while some scientists are optimistic about the chances, others are skeptical or excited.
I would say we are in the middle, and that AI isn’t the miracle cure it seems, but it certainly speeds things up, and not in a way that we would’ve imagined. Yes, the possibility of reversing the effects of aging sounds crazy at this moment. But neither does talking to a machine a few years ago. And that’s where we are today.
